Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval forThe Company has already received three other pivotal IDE appr

Related Keywords

United States ,America ,Manish Doshi ,Concept Medical Group ,Nanolute Technology ,Investigational Device Exemption ,In Stent Restenosis ,Coronary Small Vessel ,Peripheral Arterial Disease ,North America ,Concept Medical ,Superficial Femoral ,Below The Knee ,